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Summary Epidemiological studies have demonstrated adverse health effects of
environmental pollution. Diesel exhaust (DE) is an important contributor to ambient
particulate matter pollution. DE exposure has been shown to induce a pronounced
inflammatory response in the airways, with an enhanced epithelial expression of IL-
8, and Gro-a in healthy subjects. The present investigation was aimed to further
characterise the epithelial response to DE in vivo, with particular reference to
possible TH2 response, in non-atopic healthy subjects. To determine this response,
15 healthy, non-atopic non-smoking subjects with normal lung function were
exposed to DE (PM10 300 mg/m3) and filtered air during 1 h on two separate
randomised occasions. Bronchoscopy sampling of bronchial mucosal biopsies was
performed 6 h after exposure. Immunohistochemical staining were performed using
mAb for IL-10, IL-13 and IL-18 expression. DE exposure induced a significant increase
in the expression of IL-13 in the bronchial epithelium cells, 2.1 (1.35–4.88) Md (Q1–
Q3) vs. air 0.94 (0.53–1.23); P ¼ 0:009: No significant changes were seen in IL-10 and
IL-18 expression. This finding suggests an TH2-inflammatory response in the airways
of non-atopic healthy individuals.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
There is now extensive evidence showing that
exposure to increased levels of ambient particulate
matter (PM) pollution is associated with worsening
of airway symptoms and lung function, increase in
asthma medication use, emergency room visits and
hospital admissions for respiratory diseases.1–3
Asthmatic subjects have been suggested to be
particularly susceptible to the adverse health
effects of PM pollution, but it is clear that even
subjects without allergy and respiratory disease are
affected and will experience mucosal and airway
symptoms associated with elevation of PM pollution
levels.1,3 Diesel exhaust (DE) is a major contributor
to PM air pollution and has been identified as a
reactive pollutant, which contributes to adverse
health effects.
The capacity of DE to produce adverse effects on
human airways has been addressed in a series of
experimental studies in healthy and asthmatic
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subjects using a validated system of controlled
chamber exposure.4–6
DE exposure for 1 h at a PM concentration of
300 mg/m3 has been shown to result in an inflam-
matory response in airways, with epithelial produc-
tion of IL-8 and GRO-a causing a prominent
recruitment of neutrophils into air spaces and
bronchial mucosa. This was accompanied by a
migration of CD4þ and CD8þ lymphocytes to the
airways and mast cell activation leading to secre-
tion of histamine into the air spaces, even in non-
atopic healthy individuals.7–9 DE has also been
demonstrated to adversely affect the phagocytic
function of alveolar macrophages in vitro.6 In
asthmatic subjects treated with inhaled corticos-
teroids (800–1200 mg/d). DE induced a doubling of
bronchial responsiveness to methacholine 1 day
after exposure.10
The relationship between DE and allergy has
recently come in focus. Cell culture work and
challenge studies in animals have demonstrated
that sensitisation to allergens and development of
allergic responses may be enhanced by a variety of
air pollutants, but most prominently by DE parti-
cles.11 Studies by Diaz-Sanchez and co-workers,
with local DE particle installations in the nose,
clearly suggest that DE may enhance allergen
responsiveness as well as promoting sensitisation
to neo-allergens in the nose.12–15 The question was
consequently raised whether DE could also cause a
shift towards Th2 response in the lungs. If this does
indeed occur, it would greatly affect how we regard
the increasing use of diesel engines in our society.
Therefore, in this study, we examined the
hypothesis that, in healthy non-atopic subjects,
exposure to DE would induce a shift towards a TH2
cytokine response in the bronchial mucosa, and/or
suppress a TH1 response.
Methods
The exposure protocol has been presented in detail
previously.7,8 Briefly, fifteen healthy non-atopic,
non-smoking subjects (11 males, 4 females) mean
age 24 years (range 21–28 yr), were recruited. Each
subject was exposed to air or DE for 1 h in an
exposure chamber, on two different occasions. Air
and DE exposure were performed in a randomised
sequence at least 3 weeks apart. Six hours after
each exposure, bronchoscopy was performed to
obtain endobronchial mucosal biopsies. To avoid
biopsy artefacts, biopsies were taken from one side
during the first bronchoscopy and from the con-
tralateral side during the second bronchoscopy.
Biopsies were fixed overnight in chilled acetone
(–201C) containing the protease inhibitors iodoace-
tamide and phenylmethyl sulfonyl fluoride. After
fixation, biopsies were processed into glycolmetha-
crylate (GMA) resin and stored at –201C until
cutting and immunostaining.16 Two micron thick
sections were cut and placed on poly L-lysine
treated glass slides. Endogenous peroxidases were
inhibited using 0.1% sodium azide and 0.3% hydro-
gen peroxide. Non-specific antibody binding was
blocked with undiluted culture medium containing
bovine serum albumin and fetal calf serum, before
the primary monoclonal antibodies (mAb) directed
against IL-10, IL-13 and IL-18 (Table 1) were applied
and incubated at room temperature overnight.
After rinsing in Tris-buffered saline (TBS), biotiny-
lated rabbit anti-mouse IgG F(ab0)2 (Dako Glostrup
Denmark) was applied for 2 h, followed by the
streptavidin–biotin horseradish peroxidase complex
(Dako) for another 2 h. Sections were developed
with 3,3-diaminobenzidine and counterstained with
Mayer’s hematoxylin. TBS and mAb IgG were used
as negative controls. Insufficient biopsy material
was available to allow analysis of other cytokines.
All slides were coded and analysed by an
observer blinded to the exposure regime. Positive
staining was analysed based on red/green/blue
colour composition, in areas of intact well orien-
tated epithelium, with the assistance of compu-
terised image analysis (Leica Q500IW, Leica,
Cambridge, UK), as previously described.8
Statistic analyses
Each subject acted as their own control, and
variables were analysed using Wilcoxon’s paired
rank test (SPSS for Windows version 10.1.4). P-
values o0.05 were considered significant.
Results
Following DE exposure, immunohistochemical ana-
lysis showed a significant increase in IL-13 in the
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Table 1 Monoclonal antibodies used for immuno-
histochemical staining of the bronchial epithelium.
Antibody Clone Source
IL-10 23738.111 R&D SYSTEM Abingdon, UK
IL-13 32116.11 R&D SYSTEM Abingdon, UK
IL-18 125-2H R&D SYSTEM Abingdon, UK
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epithelium (2.05; 1.35–2.05, median and inter-
quartile range, compared to biopsies obtained after
filtered air (0.94; 0.53–1.23; P ¼ 0:009) (Table 2,
Fig. 1). No difference was detected in expression of
IL-10 or IL-18 (Table 2).
Discussion
The present study demonstrated that exposure of
healthy human subjects to freshly generated DE
significantly enhances expression of IL-13 protein in
the bronchial epithelium, but does not significantly
change the expression of either IL-10 or IL-18. To
the best of our knowledge, this is the first study
demonstrating a TH2 related cytokine response in
the lungs of non-atopic individuals exposed to DE.
DE is a major component in ambient air pollution
and has been shown to cause mucosal symptoms,
increase BHR and have strong pro-inflammatory
effects in the airways.8–10 Since diesel particles
have previously been demonstrated to cause Th2
responses in the nose, we hypothesised that this
might also occur in the lower airways. To examine
this, we determined the expression of Th1 and Th2
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Table 2 Percentage area of bronchial epithelium expressing IL-10, IL-13 and IL-18 in biopsies obtained 6 h after
exposure of healthy subjects to diesel exhaust vs. filtered air.
IL-10 IL-13 IL-18
AIR 1.92 (1.52–2.61) 0.94 (0.53–1.23) 3.83 (3.02–6.41)
DE 2.31 (1.03–2.94) 2.05 (1.35–4.88) 6.1 (1.80–11.0)
NS P ¼ 0:009 NS
All values are presented as percentage of epithelial area and given as medians with interquartile ranges. Statistical comparisons
by Wilcoxon’s paired rank test.
Figure 1 IL-13 expression in the bronchial epithelial mucosa after exposure to filtered air and diesel exhaust (upper
panel). The black DAB colour is selected using an image analyser system and quantified within the epithelial area, as
expressed by the red computer generated colour (lower panel). Bar represents 30 mm.
DE exposure enhances the expression of IL-13 823
cytokines expression in the bronchial mucosa,
which represents a major immunocompetent sur-
face and barrier which interacts with the diesel
particles and which is also a major source of
cytokines in the airways. We were selective and
limited in the number of Th1–Th2 cytokine inves-
tigated due to the limited availability of bronchial
mucosal biopsy material.
IL-13 is an important Th2 cytokine and was
selected as the main Th2 marker in this study. It
is normally expressed in larger amounts in the
airways than IL-4, with which it shares many
properties. The similarities in effects of IL-4 and
IL-13 are due to both cytokines using the IL-4
receptor-a chain, which is a common component of
the IL-4 and IL-13 receptors.17,18 Secretion of IL-13
following local allergen challenge in atopic asthma
has been shown to strongly correlate with eosino-
phil numbers.19 In mice IL-13 directly stimulates B
cells, causing extended survival and enhanced
antibody levels. As we have previously reported
that DE results in a T-cell influx into the airways,
the present findings may provide an additional
mechanism for IL-13 to stimulate IgE antibody
production by T-cell activated B cells.7,20 Conse-
quently, the increase of the Th2 cytokine IL-13 in
the airway mucosa of non-atopic individuals may
shift the immune response in these individuals
towards an allergic pattern of response, as sug-
gested by Diaz-Sanchez et al. in their human nasal
provocation model with diesel particles.8–15 This
response could be of particular importance in
subjects with allergy or asthma, as IL-13 has been
shown to be most potent inducer of eotaxin in
airway epithelial cells as well as being able to
induce bronchial hyperresponsiveness (BHR) in
animal models of allergic asthma. This is also
consistent with our findings of a doubling of BHR
in allergic asthmatics one day after DE exposure.10
IL-13 also has a role in mucin secretion.
IL-10, was selected as a cytokine of interest for
this study, because it contributes to Th2 responses
and also has anti-inflammatory properties.21 IL-10
enhances Th2 responses, potentiates IgE produc-
tion by B cells that have become committed to IgE
production.22 The fact that IL-10 concentrations
were relatively unchanged in the present study may
reflect the early stage of the inflammatory process
at which the biopsies were collected. It would be of
interest to address this by studying biopsies at later
timepoints after exposure.
IL-18 is a proinflammatory regulatory Th1 cyto-
kine that plays an important role in NK cell
activation. Together with IL-12, IL-18 has a syner-
gistic effect on IFN-g production from T cells.23
Constitutive expression of IL-18 has been observed
within epithelium and mononuclear cells in mice.24
Mice challenged with LPS show a higher level of IL-
18 expression in their lungs than control mice and
conversely, ovalbumin-challenged mice show lower
levels of IL-18 expression compared to control
animals. In man, airways tissue from patients with
sarcoidosis express a higher level of IL-18 than
control individuals, while asthmatic airways show
lower levels of IL-18 expression compared to
controls.24 In the current study, the expression of
IL-18 varied widely between subjects, and although
the median value was slightly increased, there was
no statistically significant effect of DE exposure.
In this study, DE exposure induced an increase in
IL-13 expression in the human bronchial epithelium
of non-atopic subjects. This rise occurred at the
same time as neutrophilic, lymphocytic and mast
cell infiltration of the airways epithelium, upregu-
lation of the adhesion molecules ICAM-1 and VCAM-
1, and increased epithelial expression of the
chemokines Gro-a and IL-8.7,8 These data are
consistent with the nasal provocation studies of
Diaz-Sanchez et al. and suggest that DE may act as
an immune modulator which enhances Th2 re-
sponses in the airways of exposed individuals. DE-
enhanced IL-13 expression may increase the risk of
allergic sensitisation in previously non-atopic in-
dividuals, while in allergic asthmatic subjects, this
could be one of the mechanisms underpinning the
clinical observation of enhanced susceptibility to
particulate pollution.10
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